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Abstract
Human myometrium develops phasic contractions during labor. Phosphorylation of caldesmon (h-CaD) and extracellular
signal-regulated kinase 1/2 (ERK 1/2) has been implicated in development of these contractions, however the phospho-
regulation of these proteins is yet to be examined during periods of both contraction and relaxation. We hypothesized that
protein phosphorylation events are implicated in the phasic nature of myometrial contractions, and aimed to examine h-
CaD and ERK 1/2 phosphorylation in myometrium snap frozen at specific stages, including; (1) prior to onset of contractions,
(2) at peak contraction and (3) during relaxation. We aimed to compare h-CaD and ERK 1/2 phosphorylation in vitro against
results from in vivo studies that compared not-in-labor (NIL) and laboring (L) myometrium. Comparison of NIL (n=8) and L
(n=8) myometrium revealed a 2-fold increase in h-CaD phosphorylation (ser-789; P=0.012) during onset of labor in vivo,
and was associated with significantly up-regulated ERK2 expression (P=0.022), however no change in ERK2 phosphorylation
was observed (P=0.475). During in vitro studies (n=5), transition from non-contracting tissue to tissue at peak contraction
was associated with increased phosphorylation of both h-CaD and ERK 1/2. Furthermore, tissue preserved at relaxation
phase exhibited diminished levels of h-CaD and ERK 1/2 phosphorylation compared to tissue preserved at peak contraction,
thereby producing a phasic phosphorylation profile for h-CaD and ERK 1/2. h-CaD and ERK 1/2 are phosphorylated during
myometrial contractions, however their phospho-regulation is dynamic, in that h-CaD and ERK 1/2 are phosphorylated and
dephosphorylated in phase with contraction and relaxation respectively. Comparisons of NIL and L tissue are at risk of
failing to detect these changes, as L samples are not necessarily preserved in the midst of an active contraction.
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Introduction
Human myometrial contractions last approximately 60 seconds
and are followed by extended periods of relaxation. Whilst protein
phosphorylation cascades have been linked to myometrial contrac-
tility, little is known about the regulation of these phosphorylation
events during the periods of relaxation.
Within human myometrium, evidence exists linking the phosphor-
ylation of high molecular weight caldesmon (h-CaD) and extracellular
signal-regulated kinase 1/2 (ERK 1/2) to the generation of
contractions [1,2,3,4,5,6]. As an essential regulator of smooth muscle
contractility [1,2], h-CaD functions to inhibit myosin ATPase activity
[7,8] as well as interact with tropomyosin [9,10,11] to block the binding
site of myosin on actin. Together these two properties prevent actin-
myosin cross bridge cycling, which is critical to the generation of
contractile force [3,4]. h-CaD also possesses binding domains for
calcium (Ca
2+)-calmodulin [12], and recently significantly increased
myometrial h-CaD expression at $37 weeks gestation (relative to non-
pregnant myometrium) was correlated with decreased Ca
2+ sensitivity,
suggesting that h-CaD is a potent inhibitor of Ca
2+-induced smooth
muscle contraction [6]. Phosphorylation of h-CaD on serine residue
789, which is a known ERK phosphorylation site [5], induces
conformational changes that relieve inhibition of myosin ATPase as
well as exposing the myosin binding site on actin. Together these
changes permit actin-myosin cross bridge cycling and the subsequent
generation of contractile force. Li et al., demonstrated that h-CaD is
phosphorylated in human myometrial strips following the application
of stretch [6]. These studies reported that gestational stretch activates
focal adhesion signaling via focal adhesion kinase (FAK), which, acting
through smooth muscle Archvillin (smAV), recruits ERK to dense
plaques, leading to ERK activation and subsequent phosphorylation of
h-CaD on Ser789 [6]. Li et al., also examined h-CaD phosphorylation
in vivo, and although the authors reported significantly increased h-CaD
phosphorylation in term laboring myometrium, statistical significance
was achieved relative to non-pregnantmyometrium,withnosignificant
difference evident between term non-laboring and term laboring
human myometrium.
Given that contraction associated proteins such as h-CaD are
regulated by protein phosphorylation, we hypothesised that rapid
protein phosphorylation events may be implicated in the phasic
nature of spontaneous myometrial contractions. We aimed to test this
hypothesis using the novel approach of snap freezing myometrial
tissue at specific stages during the development of contractions,
including prior to the onset of contractions, at the peak of contraction
and during periods of relaxation between contractions. Here we
report the first evidence of phasic phospho-regulation of h-CaD and
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vitro. Furthermore, we provide the first evidence that h-CaD
phosphorylation is increased during the late gestation transition from
term, not-in-labor (NIL) myometrium to term, laboring (L)




These studies were approved by the Hunter and New England
Area Research Committee, adhering to guidelines of the
University of Newcastle and John Hunter Hospital, Newcastle,
Australia. All participants gave informed written consent. Human
myometrial samples (565610 mm) were obtained from the lower
uterine segment of term singleton pregnancies undergoing
cesarean section. Age of the participants averaged 31.7562.06
years for NIL studies and 2961.76 years for L studies (age
comparison; p=0.164). For NIL studies myometrial biopsies were
collected from women ranging from 38–39 weeks gestation
(38.8760.125 weeks, mean 6 SEM), whilst for L studies gestation
ranged from 36–42 weeks (39.860.66 weeks, mean 6 SEM)(ges-
tation comparison; p=0.09). Subjects underwent elective cesarean
section prior to the onset of labor (NIL cohort) or emergency
cesarean section after the onset of labor (L cohort). Reasons for
elective cesarean section were previous cesarean section (5
samples), 3
rd/4
th degree tear (2 samples) or placental praevia (1
samples), whilst reasons for emergency cesarean section were non-
reassuring cardiotocograph (fetal distress; 3 samples), undiagnosed
breach (2 samples), failed forceps delivery (1 sample), poor progress
(1 sample) or herpes simplex virus (1 sample). Following delivery of
the placenta, all women were administered 5 units of syntocinon
directly into an intravenous line as part of standard care for the
prevention of post-partum hemorrhage. Myometrial biopsies were
then excised 3–5 min after administration of the syntocinon. All
samples were therefore exposed to oxytocin however exposure was
brief (3–5 min). In addition, two samples from the L cohort also
received 10 units of syntocinon during the induction of labor. After
biopsy, myometrial samples were dissected from connective tissue
and either frozen in liquid nitrogen or placed into ice-cold saline
and stored at 4uC (maximum 16 h) for contractility studies.
Isometric tension recordings (myometrial bioassay)
Myometrial samples from non-laboring women were cut into
strips (76262 mm) and suspended in organ baths containing
30 ml Krebs-Henseleit buffer with 1.89 mM CaCl2. Strips were
connected to a Grass FT03C force transducer (Grass Instruments,
Quincy, MA) and 1 g passive tension applied. Buffer was replaced
five times during the first hour, with strips re-tensioned to 1 g
passive tension following each wash. Thereafter strips were
maintained at 37uC (pH 7.4) and continuously bubbled with
95% O2/5% CO2 until spontaneous rhythmic contractions
developed. Data were digitized using a Maclab8E data-acquisition
system and contraction status visualised in real time using Chart
software (ADI, Melbourne, Australia). Strips were closely moni-
tored until reaching appropriate contraction phases and then snap
frozen using liquid nitrogen (i) after 15 mins of washing but prior
to the onset of any contractions, (ii) at maximum contraction once
rhythmic contractions were established, and (iii) at maximum
relaxation between rhythmic contractions. Snap freezing was
performed by rapidly raising the tissue strips out of the organ bath
and cutting the threads tethering the strips to the transducer. The
strips were collected into 5 ml tubes that were immediately capped
and plunged into liquid nitrogen. Total time for the snap freezing
procedure was 5–7 seconds. The tissue was then stored at 280uC.
Protein extraction and one-dimensional (1D) SDS-PAGE
Frozen tissue was pulverized under liquid N2 and 100 mg tissue
homogenized in 1 ml lysis buffer (7 M urea, 2 M thiourea, 4%
CHAPS, 30 mM Tris) supplemented with PhosSTOP phospha-
tase inhibitor (Roche, Castle Hill, NSW) and Complete Mini
Protease Inhibitor (Roche). The protein extraction homogenate
was incubated at 4uC for 30 mins on a rotary mixer before being
centrifuged at 11,0006 g, for 15 min at 4uC. Supernatant was
collected and protein content determined by 2D Quant Kit (GE
Healthcare, Piscataway, NJ). Reagents and equipment were
obtained from Invitrogen (Mt. Waverley, Australia), unless stated
otherwise. Protein extracts (20 mg per lane) were loaded onto 4–
12% NuPAGE gels and separated using a Novex Mini-Cell system
at constant voltage (200 V for 50 min; Invitrogen). For ‘NIL
versus L’ studies, myometrial biopsies were pulverized and
extracted from eight non-laboring women and eight laboring
women. Samples were run across two gels with 4 non-laboring
samples, 4 laboring samples and a calibrator sample were included
on each gel.
Pro-Q Diamond Phosphoprotein Labeling
Following SDS-PAGE separation, proteins were labeled with
Pro-QH Diamond Phosphoprotein Gel Stain (Invitrogen) accord-
ing to the manufacturer’s standard instructions for staining
minigels. Pro-QH Diamond Staining was visualised using a
FujiFilm LAS-3000 Luminescent Image Analyser. Following
visualisation of Pro-QH Diamond labeling, gels were immediately
stained with SYPROH Ruby Protein Gel Stain (Invitrogen)
according to the manufacturers standard procedure for minigel
staining. SYPROH Ruby protein staining was imaged on a
FujiFilm LAS-3000 Luminescent Image Analyser. To ensure
specific phosphoprotein labeling was achieved, a Peppermint
TM
Stick molecular weight marker consisting of 2 phosphoproteins
and 4 non-phosphorylated proteins was included on all gels.
Immunoblotting
After 1D SDS-PAGE, proteins were transferred to Hybond-C
nitrocellulose (Amersham Biosciences, Buckinghamshire, UK)
using the XCell II Blot Module (Invitrogen). For anti-phosphotyr-
osine visualization, blots were first stained with SYPROH Ruby
Protein Blot stain (Invitrogen) according to the manufacturers
instructions. During immunoblotting all incubations were per-
formed on a rocking platform. Membranes were blocked in 5%
skim milk in TBS/T (500 mM NaCl, 20 mM Tris, 0.01% Tween-
20) overnight at 4uC. Blocking solution was decanted and primary
antibody applied at previously optimised dilutions in 10 mL 1%
skim milk in TBS/T for 2 h at RT. Antibodies against phospho-h-
CaD (cat.# 07-156, Cell Signaling, Lake Placid, NY), total-h-CaD
(cat.# MAB3576, Millipore, Billerica, MA), phospho-ERK 1/2
(cat.# 4377S, Cell Signaling), total-ERK 1/2 (cat.# 4695, Cell
Signaling) and phospho-MLC (cat.# sc-19849-R, Santa Cruz
Biotechnology, Santa Cruz, CA) were applied at 1:2000 dilution,
whilst antibodies against phospho-tyrosine (cat.# 03-7720,
Invitrogen) and a-smooth muscle actin (a-SMA) (cat.# A5228,
Sigma-Aldrich, Castle Hill, NSW) were applied at 1:2500 and
1:10,000 respectively. Blots were subjected to 465 min washes
with 100 mL of TBS/T. Washed blots were then incubated in
horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (cat.#
7074, Cell Signaling) or anti-mouse IgG (cat.# 7076, Cell
Signaling) secondary antibody as appropriate. Secondary antibod-
ies were applied at 1:2500 dilution in 10 mL of 1% skim milk in
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of TBS/T before immunoreactive products were detected with
enhanced chemiluminescence (ECL Western blotting reagents;
GE Biosciences, Buckinghamshire, UK) and visualized using the
Fuji Intelligent Dark Box LAS-3000 Image Reader (Fuji Photo
Film, Tokyo, Japan). To ensure internal controls, blots were first
probed with the phospho-specific antibodies before being stripped
and re-probed with antibodies against the total proteins.
Membranes were stripped by 264 min incubations in 100 mL
of 0.2 M NaOH. Stripped blots were then washed for 363 min in
TBS/T before being re-probed according to the outlined regime.
Phosphorylation of MLC was examined as a proof of concept.
Densitometry and Statistics
Densitometric analysis of immunoreactive protein bands was
performed using Multigauge software (Fuji Photo Film) supplied
with the LAS-3000. Where necessary, optical density (OD;
arbitrary units) was normalized between blots using the incorpo-
rated calibrator sample on each blot (NIL versus L studies). OD
was expressed as a percentage of the phosphorylated target
proteins relative to the total protein density. Similarly, OD of total
h-CaD and total ERK 1/2 was expressed as a percentage of a-
SMA OD, which was used as a loading control given that a-SMA
abundance in myometrium remains unchanged throughout
pregnancy [13]. Statistical analysis was conducted using Stata
9.2 software (StataCorp, College Station, TX).
The distribution of each outcome variable was assessed using a
histogram and the skewness/kurtosis test for normality. The ratio
of phospho-h-CaD to total h-CaD was skewed right, hence median
and interquartile ranges have been reported. The ratio of total h-
CaD/SMA, p-ERK 1/2/total ERK 1/2, and total ERK 1/2/
SMA were normally distributed, hence mean and standard
deviation are reported. Statistical comparisons were undertaken
comparing the NIL (n=8) and L (n=8) group. Two-sample t-tests
with equal variance were performed for the normally distributed
variables and the non-parametric equivalent, Mann-Whitney U
test, was performed for the ratio of phospho-h-CaD to total h-
CaD. Statistical analyses were carried out using Intercooled Stata
11 (StataCorp LP, College Station, Texas, USA). For all tests,
P#0.05 was considered significant.
Results
h-CaD and ERK expression in non-laboring and laboring
human myometrium
h-CaD expression and phosphorylation were examined in 86NIL
and 86L term pregnant myometrial samples via western blot
(Figure 1). Upon densitometric analysis we observed no significant
difference in total h-CaD expression between NIL and L myometrium
(P=0.567; Figure 2A). Analysis of h-CaD phosphorylation revealed a
two-fold increase of serine-789 phosphorylation following the onset of
labor in vivo (P=0.012, Figure 2B). We also examined ERK 1/2
expression and phosphorylation in these samples (Figure 1) given that
serine-789 is a known ERK phosphorylation site [5]. ERK1 protein
was undetectable. ERK2 expression was detectible and densitometric
analysesrevealed that the onset of labor wasassociated with a small yet
statistically significant increase (38%) of ERK2 expression (P=0.022;
Figure 2C).Although totalERK2 expression increased by38% during
the onset of labor, densitometric analysis revealed no change in the
ratio of phospho-ERK2/total ERK2 between NIL and L laboring
human myometrium (P=0.475; Figure 2D).
Phasic phosphorylation during myometrial contractions
in vitro
In addition to investigating the regulation of h-CaD phosphoryla-
tion during the onset of labor in vivo,w ee x a m i n e dh - C a D
phosphorylation during the development of contractions in vitro.W e
obtained myometrial biopsies at caesarean section from women at
term. These biopsies were dissected into strips and the strips
suspended in organ baths under tension. We then snap froze the
myometrial strips at specific stages during the development of
spontaneous contractions, including (1) prior to the onset of any
contractions, (2) at peak contraction and (3) during relaxation between
individual contractions (see Figure 3A). As a proof of concept, we
analysed myosin light chain (MLC) phosphorylation (serine-19) at
these specific stages during the development of contractions. We
observed that non-contracting myometrium exhibited minimal levels
of MLC phosphorylation. The transition from non-contractile
myometrium at point 1 to peak contraction at point 2 however was
associated with extensive up-regulation of MLC phosphorylation
(Figure 3B). Furthermore, the transition from peak contraction at
Figure 1. h-CaD and ERK 1/2 expression in NIL and L term human myometrium. NIL and L myometrial protein extracts were separated by
SDS-PAGE and western transferred onto nitrocellulose membrane. Membranes were probed with antibodies against phospho-h-CaD (1:2000), total h-
CaD (1:2000), phospho-ERK 1/2 (1:2000), total ERK 1/2 (1:2000) and a-SMA (1:10000). A total 86NIL and 86L samples were analysed. Representative
image demonstrates detection of these proteins on a single blot containing 46NIL and 46L myometrial samples, as well as a calibrator sample that
was included to allow densitometric comparison across separate blots. Mr=relative molecular mass61000.
doi:10.1371/journal.pone.0021542.g001
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MLC phosphorylation, demonstrating that within our model MLC is
phosphorylated and de-phosphorylated in phase with contractions.
Having demonstrated the efficacy of our model we proceeded to
investigate h-CaD expression during the establishment of contractions
in vitro. Consistent with our in vivo ‘NIL versus L’ data, the
establishment of spontaneous contractions in vitro was associated with
increased phosphorylation of h-CaD (Figure 3B). When normalised
against total h-CaD protein, densitometric analysis of five replicates
revealed that the transition from non-contractile tissue at point 1 to
peak contraction at point 2 was associated with an average two-fold
increase in h-CaD phosphorylation (P=0.043, Figure 3C). Further-
more, the transition from peak contraction at point 2 to relaxed tissue
at point 3 was associated with a reduction in h-CaD phosphorylation.
The transition from point 2 to point 3 corresponds to 5–8 min of
temporal spacing, and during this time h-CaD phosphorylation
declined to levels that were not significantly elevated above that of
tissue preserved at point 1 (P=0.138; Figure 3C).
During in vitro studies we also examined ERK 1/2 phosphor-
ylation as the potential regulator of h-CaD phosphorylation.
ERK1 detection was minimal however ERK2 was highly
expressed in human myometrial samples utilised for the in vitro
studies. Where our comparison of NIL and L myometrium failed
to show a difference in ERK2 activation, our in vitro analyses
demonstrated that the onset of contractions was associated with
increased ERK2 phosphorylation. Figure 3B clearly illustrates that
the transition from non-contractile tissue (point 1) to tissue at peak
contraction (point 2) is associated with an extensive up-regulation
of ERK2 phosphorylation. Furthermore, the transition from peak
contraction (point 2) to relaxation (point 3) was associated with a
decline in ERK2 phosphorylation (Figure 3B). ERK2 phosphor-
ylation therefore increased during the transition from non-
contractile tissue to tissue at peak contraction, and then declined
during the transition from peak contraction to relaxation.
Although ERK1 expression was substantially less then ERK2,
ERK1 exhibited the same pattern of protein phosphorylation in
phase with onset and subsidence of contractions. This phasic
pattern is consistent with our findings on h-CaD phosphorylation.
Phosphoprotein labeling in human myometrium
We sought to visualise global changes in protein phosphoryla-
tion associated with the development of contractions in vitro.
Specific labeling of phosphoproteins with Pro-QH Diamond
Phosphoprotein Gel Stain was confirmed using the Peppermint
stick marker included on all gels, as outlined in methods. Pro-QH
Diamond staining of myometrial proteins from contraction phases
1, 2 and 3 revealed that the development of contractions in vitro
was associated with increased phosphorylation of a cohort of
Figure 2. Densitometric analysis of h-CaD and ERK2 expression in NIL and L myometrium. Densitometric analysis was performed for
86NIL and 86L myometrial samples following immunodetection of phospho-h-CaD, total h-CaD, phospho-ERK 1/2, total ERK 1/2 and a-SMA. (A)
Onset of labor was associated with a statistically significant, 2-fold up-regulation in h-CaD phosphorylation, whilst (B) total h-CaD expression
remained unchanged. (C) ERK2 phosphorylation remained unchanged following the onset of labor, however (D) total ERK2 expression underwent a
statistically significant 1.4-fold up-regulation in association with the onset of labor. *p,0.05, **p,0.02.
doi:10.1371/journal.pone.0021542.g002
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changes during the transition from non-contractile tissue to tissue
at peak contraction are indicated by the black arrowheads
(Figure 4A). The major phosphoprotein band observed had a
Mr of ,50610
3, however at least 5 high molecular weight proteins
(Mr.100610
3) and a protein with Mr of ,80610
3 were also
observed to undergo phospho regulation. A series of other
phosphoprotein bands also exhibited increased phosphorylation
although to varying lesser extents. The transition from peak
contraction at point 2 to relaxation at point 3 was associated with
reduced phosphorylation of multiple proteins. This was particu-
larly evident for the two high molecular weight phosphoprotein
bands labeled (i) and (ii), and is consistent with the phasic
phosphorylation profiles observed for h-CaD and ERK 1/2. In
contrast, other proteins were phosphorylated at peak contraction
and remained phosphorylated despite the myometrium having
transitioned into relaxation, such as phosphoprotein band (iii).
Two proteins with Mr of 23610
3 and 25610
3 (indicated by white
arrowheads) exhibited increased phosphorylation during the
transition from peak contraction at point 2 to relaxation at point
3. The identities and characterisation of these protein bands is the
subject of further investigation.
Our complementary analyses into the specific detection of
tyrosine phosphorylation events yielded similar results (Figure 4B).
Immunoblot detection of phospho-tyrosine residues demonstrated
that the transition from non-contractile tissue at point 1 to tissue at
peak contraction at point 2 was associated with increased tyrosine
phosphorylation of at least six myometrial proteins. Of these the
major phospho-tyrosine protein band observed had a Mr of
,115610
3. As per the Pro-Q Diamond staining, we again
observed that the transition from peak contraction at point 2 to
relaxation at point 3 was associated with reduced tyrosine
phosphorylation of specific proteins, such as band (iv) for example,
whilst tyrosine phosphorylation of other proteins, such as band (v),
remained high despite the transition into relaxation. These
phospho-tyrosine protein bands are now being characterized.
Discussion
At labor the human uterus develops co-ordinated regular
contractions that force the fetus through a softened cervix to
achieve delivery. Previous studies of human myometrium have
compared tissue obtained from women prior to the onset of labor
with samples taken after the onset of labor; yet even during labor
the uterus is relaxed for the majority of time. Here we have
developed and demonstrated a method for studying the molecular
events associated with contraction and relaxation in term
myometrial tissue.
Li et al. 2009 have previously reported that h-CaD expression is
significantly up-regulated in human myometrium at $37 weeks
gestation [6]. Statistical significance was however achieved relative
to non-pregnant tissue as opposed to term NIL myometrium. In
the presently reported studies we compared term NIL myometri-
um against term L myometrium and have provided the first
evidence that h-CaD phosphorylation is increased during this late
gestation transition in vivo (Figure 2B). Increased phosphorylation
of h-CaD during labor is consistent with its role as a
phosphorylation-regulated actin binding protein and regulator of
smooth muscle contraction [1,2,5,7,8]. With no further elabora-
tion on these ‘NIL versus L’ results, one could assume that h-CaD
phosphorylation remains increased for the duration of labor. Data
obtained from our in vitro model however indicates that this is not
actually the case. We took the novel approach of snap-freezing
non-laboring myometrial strips at specific stages during their
transition from non-contractile tissue through to tissue engaged in
rhythmic contractions that arise spontaneously once myometrium
is suspended under tension (in organ baths). Unlike ordinary
tension assays or ‘NIL versus L’ comparisons, we sub-divided our
contractile samples into those preserved at peak contraction and
those preserved at relaxation. This approach provides additional
insight into changes that occur during the transition from peak
contraction to intervals of relaxation that exist in between
individual contractions. Our data on MLC provides ‘proof of
concept’ for this approach, as MLC was phosphorylated in tissue
preserved at peak contraction, yet minimally dephosphorylated in
Figure 3. h-CaD and ERK 1/2 phosphorylation during myome-
trial contractions in vitro. (A) Myometrial strips were snap frozen at
specific stages during the development of contractions. The tissue was
then pulverised and subjected to protein extraction. Protein (20 mg)
was separated by 1D PAGE and transferred to a nitrocellulose
membrane. (B) Membranes were probed with antibodies against
phospho-h-CaD (1:2000), total h-CaD (1:2000), phospho-ERK 1/2
(1:2000) and total ERK 1/2 (1:2000), as well as a-SMA (1:10000),
representative images shown of 5 replicates. (C) Non-parametric
analyses of the non-normalised raw data revealed a statistically
significant 2-fold increase in h-CaD phosphorylation during the
transition from point 1 to point 2. No significant difference was
observed between contraction points 1 and 3 or 2 and 3. *p,0.05.
Mr=relative molecular mass61000.
doi:10.1371/journal.pone.0021542.g003
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(Figure 3B).
Our studies reveal that phosphorylation of h-CaD parallels the
onset and subsidence of contractions. That is, h-CaD is
phosphorylated at the peak of myometrial contraction, and de-
phosphorylated during periods of relaxation between individual
contractions. This pattern of phasic phosphorylation was also
observed for ERK 1/2, and provides indirect evidence that ERK
1/2 regulates the phasic phosphorylation of h-CaD on serine-789
during myometrial contractions in vitro, which is consistent with
serine-789 being a known ERK phosphorylation site [5].
Results of our global phosphorylation analyses demonstrate that
ERK 1/2 and h-CaD are just two members of a cohort of proteins
that exhibit phasic phosphorylation during myometrial contrac-
tions. We visualised at least 14 phosphorylation events associated
with the development of contractions. A sub-set of these proteins
underwent dephosphorylation during relaxation, while others
remained phosphorylated.
Our evidence of phasic phosphorylation in parallel to contractions
is of key significance as it demonstrates that phasic phosphorylation
events may be missed by traditional experimental approaches. For
instance, during our ‘NIL versus L’ analyses we observed increased h-
CaDphosphorylationduringtheonsetoflabor,aswellassignificantly
up-regulated expression of ERK2 (Figure 2). Examination of
ERK2 phosphorylation however revealed no change during labor
(Figure 2D), despite contrasting in vitro evidence demonstrating that
ERK 1/2 is phosphorylated at peak contraction (Figure 3B). The
inability of the ‘NIL versus L’ comparison to identify changes in ERK
1/2 phosphorylation is attributed to the fact that laboring samples
are inevitably a heterogeneous group. That is, although all the
myometrial samples from our L cohort were obtained from women
classified clinically as ‘in labor’, samples are not necessarily excised
and preserved in the midst of an active contraction. In fact, given a
typical situation where individual contractions are shorter then the
interval between contractions, it is actually more likely that laboring
samples are preserved during relaxation as opposed to contraction. As
our data have shown, significant differences in protein phosphory-
lation and thus regulation exist between these two contraction states
that must be taken into account during experimental design and
interpretation of results. So whilst comparing NIL myometrium
against L myometrium does indeed have the capacity to highlight
some contraction-associated changes in the myometrium, such as h-
CaD phosphorylation, other changes are far more transient and as
such may only be captured at very specific stages of contraction, such
as ERK 1/2 phosphorylation. Recognizing the limitations of the
‘NIL versus L’approach raises obvious questions as to whether phasic
myometrial phosphorylation events could actually be measured in
vivo, and if so how could it be achieved?
This investigation provides a unique insight into phasic
phosphorylation events that occur during myometrial contractions
Figure 4. Protein phosphorylation associated with myometrial contractility. Myometrial strips were snap frozen at specific stages during
the development of contractions. The tissue was then pulverised, protein extracted and separated by 1D SDS-PAGE. (A) Phosphorylated myometrial
proteins were labelled in gel with Pro-QH Diamond Phospho Stain and visualised using a FujiFilm LAS-3000 luminescent image analyser. The gel was
then SYPROH Ruby Protein stained to visualise total protein and ascertain equal loading. Lanes MP and MT illustrate the Peppermint
TM Stick molecular
weight marker labelled with Pro-QH Diamond Stain and SYPRO Ruby Protein Stain respectively. Dotted line indicates removal on none-relevant gel
lanes. (B) Separated proteins were western transferred to nitrocellulose membrane. Total protein loading was visualised using SYPRO Ruby Blot Stain
and equal loading across lanes confirmed. Membranes were then probed with mouse anti-phosphotyrosine (1:2500) and anti-mouse IgG-HRP
(1:2500). The immunoreactive bands were detected using a FujiFilm LAS-3000 luminescent image analyser. Positive and negative controls were
protein extracts from capacitated and non-capacitated human spermatozoa respectively. Black arrowheads and white arrowheads indicate
phosphorylation events associated with contraction and relaxation respectively. (i), (ii) and (iv) highlight bands exhibiting phasic phosphorylation,
whilst phosphorylation remained increased for bands (iii) and (v). Representative images shown from 3 replicates. Mr=relative molecular mass61000.
MT=molecular weight marker stained for total protein detection, MP=molecular weight marker stained for phospho protein detection.
doi:10.1371/journal.pone.0021542.g004
Phasic Phosphorylation in Human Myometrium
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21542in humans. We have demonstrated that h-CaD phosphorylation
increases late in gestationduringthe onset of labor in vivo. Venturing
beyond this, we further demonstrate that although h-CaD is
phosphorylated during the development of contractions, the
regulation of serine-789 phosphorylation is actually phasic, in that
h-CaD is once again de-phosphorylated during periods of
relaxation. We have shown that in humans the transition from
term, NIL myometrium to term L myometrium is associated with
up-regulated ERK2 expression, and that during the development of
spontaneous contractions in vitro ERK 1/2 demonstrates the same
phasic phosphorylation exhibited by h-CaD. We demonstrate that
h-CaD and ERK 1/2 are just two members of a cohort of proteins
subjected to this type of phasic regulation, and we reveal that the
transient nature of these phosphorylation events impedes our ability
to capture evidence of their existence using traditional experimental
approaches. Finally, where protein phosphorylation status is of
concern, we stress the importance of considering the marked
changes that exists between contraction and relaxation phases of
human myometrium during experimental design and interpretation
of results.
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